You didn't ask a question so why do you expect an answer?
dont dodge , you knock the lugs down the sewer drain,what would you do?...I can see you're wrestling with this.
Perhaps, unlike you, the guy has a brain and knows LLY has several drugs in development and testing that could cause an increase in earnings after 2014. Maybe a long term guy that wants to buy when the stock is cheap.
It is truly sad you couldn't answer his question without implying he doesn't know of the present situation with LLY.
Long term it may be okay but I wouldn't buy now. They lost a couple of patents unexpectedly and have some others that are going to expire soon.
If the pipeline comes through, it might be okay in two or three years. A dividend cut wouldn't surprise me in the near future.
They have the worst patent-cliff situation in big, domestic pharma. They are in process of losing Zyprexa and Gemzar - and Cymbalta expiry isn't far off either.
LLY hasn't made acquisitions which would enable them to really cut costs, their dividend payount is too great and they don't buy back shares or slash R & D. What's to like?